IRADIMED CORP — Director's Dealing 2020

Feb 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2020-02-18

Reporting Person: JOHNSON BRENT (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-18	Common Stock	M	12106	$0.93	Acquired	15046	Direct
2020-02-18	Common Stock	S	12106	$26	Disposed	2940	Direct
2020-02-19	Common Stock	M	7453	$0.93	Acquired	10393	Direct
2020-02-19	Common Stock	S	7453	$26	Disposed	2940	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-18	Stock Option (Right to Buy)	$0.93	M	12106	Disposed	2022-11-01	Common Stock (12106)	Direct
2020-02-19	Stock Option (Right to Buy)	$0.93	M	7453	Disposed	2022-11-01	Common Stock (7453)	Direct

Footnotes

F1: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2: This transaction was executed in multiple trades at prices ranging from $25.81 to $26.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $26.00 to $26.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.